Market Tracker

10/24 7:05am ET

Gilead Sciences Inc (NASDAQ:GILD)

Thursday’s Trading Day
107.18 +1.09 / +1.03%
Data as of Oct 23
Day’s Change
Friday’s Pre-Market   Switch to standard view »
106.41 -0.77 / -0.72%
 
Volume: 427.00

Today’s Trading

Previous close106.09
Today’s open106.64
Day’s range-- - --
Volume13,872,582
Average volume (3 months)14,262,464
Market cap$160.4B
Dividend yield--
Data as of 10/23/2014

Growth & Valuation

Earnings growth (last year)+10.37%
Earnings growth (this year)+293.44%
Earnings growth (next 5 years)+18.05%
Revenue growth (last year)+16.72%
P/E ratio24.1
Price/Sales10.23
Price/Book14.32

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen Inc+3.61+2.51%
BIIBBiogen Idec Inc+6.99+2.26%
BAXBaxter International...+0.73+1.07%
GEVASynageva BioPharma C...+3.69+5.10%
Data as of 10/23/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)$1.93
Annual revenue (last year)$11.2B
Annual profit (last year)$3.1B
Net profit margin27.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts